Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study

Epilepsy Research

Volumn 120, Issue , 2016, Pages 7-12

  Chung, Steve ^a   Ceja, Hugo ^b   Gawłowicz, Jacek ^c   McShea, Cindy ^d   Schiemann, Jimmy ^d   Lu, Sarah ^e  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^d UCB PHARMA   (Belgium)

^e GLAXOSMITHKLINE   (China)

Author keywords

Antiepileptic drug; Extended release; Levetiracetam; Long term; Monotherapy; Partial onset seizures

Indexed keywords

ETIRACETAM; PLACEBO; ANTICONVULSIVE AGENT; DELAYED RELEASE FORMULATION; PIRACETAM;

ABNORMAL DREAMING; ABORTION; AGED; AGITATION; ANGER; ANXIETY; APHASIA; ARTICLE; CHILD; CONTROLLED STUDY; CONVULSION; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOCAL EPILEPSY; GRAND MAL EPILEPSY; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVOUSNESS; NOCTIPHOBIA; PARALYSIS; PHOBIA; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SLEEP DISORDER; SOMNOLENCE; SUICIDAL IDEATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT; ADULT; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; COMBINATION DRUG THERAPY; DELAYED RELEASE FORMULATION; EPILEPSIES, PARTIAL; FOLLOW UP; SEIZURES;

ADULT; ANTICONVULSANTS; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PIRACETAM; SEIZURES; TREATMENT OUTCOME;

EID: 84958720830     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2015.11.017     Document Type: Article

References (14)

1. Bautista R.E., Rundle-Gonzalez V. Effects of antiepileptic drug characteristics on medication adherence. Epilepsy Behav.: E&B 2012, 23:437-441.
2. Ben-Menachem E., Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam study group. Epilepsia 2000, 41:1276-1283.
3. Besag F.M., Patsalos P.N. New developments in the treatment of partial-onset epilepsy. Neuropsychiatr. Dis. Treat. 2012, 8:455-464.
4. Carpay J.A., Aldenkamp A.P., van Donselaar C.A. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure 2005, 14:198-206. (The journal of the British Epilepsy Association).
5. Cereghino J.J., Biton V., Abou-Khalil B., Dreifuss F., Gauer L.J., Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000, 55:236-242.
6. Chung S., Ceja H., Gawlowicz J., Avakyan G., McShea C., Schiemann J., Lu S. Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study. Epilepsy Res. 2012, 101:92-102.
7. French J.A., Wang S., Warnock B., Temkin N. Historical control monotherapy design in the treatment of epilepsy. Epilepsia 2010, 51:1936-1943.
8. Haag A., Strzelczyk A., Bauer S., Kuhne S., Hamer H.M., Rosenow F. Quality of life and employment status are correlated with antiepileptic monotherapy versus polytherapy and not with use of newer versus classic drugs: results of the Compliant 2006 survey in 907 patients. Epilepsy Behav.: E&B 2010, 19:618-622.
9. Harms S.L., Eberly L.E., Garrard J.M., Hardie N.A., Bland P.C., Leppik I.E. Prevalence of appropriate and problematic antiepileptic combination therapy in older people in the nursing home. J. Am. Geriatr. Soc. 2005, 53:1023-1028.
10. Peltola J., Coetzee C., Jimenez F., Litovchenko T., Ramaratnam S., Zaslavaskiy L., Lu Z.S., Sykes D.M., Levetiracetam X.R.N.S. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial. Epilepsia 2009, 50:406-414.
11. Rouits E., Burton I., Guenole E., Troenaru M.M., Stockis A., Sargentini-Maier M.L. Pharmacokinetics of levetiracetam XR 500 mg tablets. Epilepsy Res. 2009, 84:224-231.
12. Shorvon S.D., Lowenthal A., Janz D., Bielen E., Loiseau P. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam study group. Epilepsia 2000, 41:1179-1186.
13. Stepanova D., Beran R.G. Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs). Seizure 2014, 23:371-376. (The journal of the British Epilepsy Association).
14. UCB, Inc. Keppra XR® (levetiracetam) US Prescribing Information 2015, Availble from: 〈http://keppraxr.com/includes/pdf/KeppraXR_MedicationGuide_FullPrescribingInformation.pdf [accessed 11 May 2015].